|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/16 | |
| A61K 9/20 | |||
| A61K 38/26 |
| (11) | Patento numeris | 2863895 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13729743.8 |
| Europos patento paraiškos padavimo data | 2013-06-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/062751 |
| Data | 2013-06-19 |
| (87) | Numeris | WO 2013/189988 |
| Data | 2013-12-27 |
| (30) | Numeris | Data | Šalis |
| 12172739 | 2012-06-20 | EP | |
| 201261662456 P | 2012-06-21 | US |
| (72) |
BJERREGAARD, Simon, DK
SAUERBERG, Per, DK
NIELSEN, Flemming Seier, DK
PEDERSEN, Betty Lomstein, DK
SKIBSTED, Erik, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | TABLET FORMULATION COMPRISING A PEPTIDE AND A DELIVERY AGENT |
| TABLET FORMULATION COMPRISING A PEPTIDE AND A DELIVERY AGENT |